TSX:AVCN - Toronto Stock Exchange - CA05368K1003 - Common Stock - Currency: CAD
Overall AVCN gets a fundamental rating of 2 out of 10. We evaluated AVCN against 35 industry peers in the Pharmaceuticals industry. The financial health of AVCN is average, but there are quite some concerns on its profitability. AVCN has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -12.17% | ||
ROE | -83.57% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 53.44% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -4.44 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.85 | ||
Quick Ratio | 0.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
TSX:AVCN (6/6/2025, 7:00:00 PM)
0.28
+0.02 (+5.66%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.22 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 10.21 | ||
P/tB | 13.94 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -12.17% | ||
ROE | -83.57% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 53.44% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 60.1% | ||
Cap/Sales | 1.95% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.85 | ||
Quick Ratio | 0.37 | ||
Altman-Z | -4.44 |